miR-193a and LRRC1 expression in NSCLC tumor tissues and adjacent normal tissues, and in DDP-resistant tissues and DDP-sensitive tissues were tested by western blot analysis and RT-qPCR. This evidence concerns the gene LRRC1 and neoplasm.